top of page


We're in Bilbao, Spain for Eurogin 2023

The GeneFirst team and I are very excited to now be in Spain and getting ready for Eurogin 2023 to start tomorrow.

We are looking forward to speaking to delegates about our Papilloplex® HR-HPV mRNA kit which is designed to complement the Papilloplex® HR-HPV DNA kit to identify the risk of cervical cancer in HPV-positive individuals without the need to monitor for the persistence of infection.

We are delighted to be joined on our stand with our partner PrimaDiag - a French company that develops compact robotic platforms for the rapid automation of a wide variety of clinical and life science applications and in particular molecular biology.

GeneFirst and PrimaDiag have been collaborating on the automation of GeneFirst diagnostic tests on PrimaDiag’s ACSIA robotic system with the goal to provide a complete end-to-end workflow solution to cater to the changing needs of clinical laboratories today.  Combining the unique features of the Papilloplex® High Risk HPV DNA kit and the ACSIA Automation System, we bring to the market a molecular HPV screening and triage strategy that is highly innovative and clinically driven to better risk stratify women infected with HPV.

Come and visit us on stand CO4 to find out more - I look forward to meeting you there.

Rick Bhatt, Head of Business Development, GeneFirst

bottom of page